Literature DB >> 19645639

Understanding Australia's influenza pandemic policy on the strategic use of the antiviral drug stockpile.

James M McCaw1, James G Wood, Emma S McBryde, Terry M Nolan, Joseph T Wu, Marc Lipsitch, Jodie McVernon.   

Abstract

Targeted post-exposure prophylaxis represents a more efficient use of the stockpile than treatment alone.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19645639      PMCID： PMC3073016          DOI： 10.5694/j.1326-5377.2009.tb02720.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


  7 in total

1.  Containing pandemic influenza at the source.

Authors:  Ira M Longini; Azhar Nizam; Shufu Xu; Kumnuan Ungchusak; Wanna Hanshaoworakul; Derek A T Cummings; M Elizabeth Halloran
Journal:  Science       Date:  2005-08-03       Impact factor: 47.728

2.  Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials.

Authors:  M Elizabeth Halloran; Frederick G Hayden; Yang Yang; Ira M Longini; Arnold S Monto
Journal:  Am J Epidemiol       Date:  2006-11-06       Impact factor: 4.897

3.  Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic.

Authors:  James M McCaw; Jodie McVernon
Journal:  Math Biosci       Date:  2007-03-12       Impact factor: 2.144

4.  Strategies for mitigating an influenza pandemic.

Authors:  Neil M Ferguson; Derek A T Cummings; Christophe Fraser; James C Cajka; Philip C Cooley; Donald S Burke
Journal:  Nature       Date:  2006-04-26       Impact factor: 49.962

5.  Pandemic potential of a strain of influenza A (H1N1): early findings.

Authors:  Christophe Fraser; Christl A Donnelly; Simon Cauchemez; William P Hanage; Maria D Van Kerkhove; T Déirdre Hollingsworth; Jamie Griffin; Rebecca F Baggaley; Helen E Jenkins; Emily J Lyons; Thibaut Jombart; Wes R Hinsley; Nicholas C Grassly; Francois Balloux; Azra C Ghani; Neil M Ferguson; Andrew Rambaut; Oliver G Pybus; Hugo Lopez-Gatell; Celia M Alpuche-Aranda; Ietza Bojorquez Chapela; Ethel Palacios Zavala; Dulce Ma Espejo Guevara; Francesco Checchi; Erika Garcia; Stephane Hugonnet; Cathy Roth
Journal:  Science       Date:  2009-05-11       Impact factor: 47.728

6.  Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy.

Authors:  Joseph T Wu; Gabriel M Leung; Marc Lipsitch; Ben S Cooper; Steven Riley
Journal:  PLoS Med       Date:  2009-05-19       Impact factor: 11.069

7.  Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs.

Authors:  James M McCaw; James G Wood; Christopher T McCaw; Jodie McVernon
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240
  7 in total
  3 in total

1.  Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.

Authors:  Aeron C Hurt; Siti Sarah Nor'e; James M McCaw; Helen R Fryer; Jennifer Mosse; Angela R McLean; Ian G Barr
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

2.  Diagnosis and antiviral intervention strategies for mitigating an influenza epidemic.

Authors:  Robert Moss; James M McCaw; Jodie McVernon
Journal:  PLoS One       Date:  2011-02-04       Impact factor: 3.240

3.  Pandemic controllability: a concept to guide a proportionate and flexible operational response to future influenza pandemics.

Authors:  J M McCaw; K Glass; G N Mercer; J McVernon
Journal:  J Public Health (Oxf)       Date:  2013-06-03       Impact factor: 2.341
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.